Mitral Stenosis Flashcards

1
Q

MC Etiology of MS

A

Rheumatic fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Clinical presentation of MS

A
  • Dyspnea
  • Fatigue
  • Palpitations
  • Hemoptysis
  • Afib
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Physical Exam findings characterstic of MS

A
  • Loud 1st heart sound
  • Diastolic rumble
  • Opening snap
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Modality used for definitive diagnosis of MS

A

Echocardiogram

  • Valve area
  • Valve morphology
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Normal and abnormal MVA

A
  • Normal: 4.0-5.0 cm2
  • Symptomatic MS: <2.5 cm2 (<1.5 cm2 at rest)
  • Critical MS: < 1.0 cm2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Natural History of MS

A
  • Continuous progressive lifelong disease
  • Slow, stable early course
    • latent period of 20-40 years after Rheumatic fever to onset of sx.
  • Onset of symptoms to disability : ~ 10 years
  • Atrial fibrillatin (30-40%)
    • MC in older pts (50-60%)
    • Often paroxysmal at first
    • Indicated relatively advanced MS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Characteristics of Atrial Fibrillation with MS

A

MC in older pts (50-60%)

Often paroxysmal at first

Indicated relatively advanced MS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

% of MS patients asymptomatic on presentation

A

>80%

(60% with no progression of symptoms)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

% of MS patients in NSR

A

45-50% (46%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

% of MS patients that are symptomatic on presentation

A

0-15%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

% of MS patients with severe pulmonary hypertension

A

<3%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MCC of death in MS patients

A
  • CHF (60-65%)
  • Systemic embolism (20-30%)
  • Pulmonary embolism (10%)
  • Infection (1-5%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Characteristics of Pulmonary Hypertension in MS

A
  • Elevated at rest and can become near systemic pressures with exercise
  • PA systolic > 60 mmHg significantly affects RV performance
  • LA pressure > 30 mmHG results in reduced lung compliance and pul edema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MS characteristics ammenable to MV repair

A
  • Prominant opening snap
  • No calcification
  • Pliable leaflets
  • Commissural fusion
  • Normal Chordae and papillary muscles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Balloon vs. Open Commissurotomy

A
  • Based upon surgeon experience
  • LA thrombus or MR = NO BALLOON
  • MR occurs in 2-5% of patients after open commissurootomy
    • Mild postocommissurotomy MR has little effect on long-term surival or need for MVR
  • 50% of commissurotomy patients witll require addittional operation (i.e. MVR) within 20 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Indictions for Surgical Intervention for MS

A
  • Symptomatic patients (i.e. NHYA III or IV)
    • MVA < 1.5 cm2
    • PA pressures > 50 (rest) or > 60 (with exercise)
  • Asymptomatic patients:
    • New onset Atrial Fibrillation
    • LA thrombus or embolism after anticoagulation
    • PA pressure > 60 at rest
17
Q

Surgical Procedures of MS

A
  • Closed mitral commissurotomy
  • Open mitral commissurotomy +/- anterior leaflet augmentation
  • MVR
    • Thick anterior leaflet
    • Calficication
    • Mitral regurgitation
    • Thick, short chordae
18
Q

MVR Surgical Options

A
  • Bioprosthesis
  • Mechanical prosthesis
  • MV homograft
19
Q

Risks associated with MVR

A
  • Type of prosthesis not a factor
  • Previous valvotomy or commissurotomy not a factor
  • NHYA class
  • MR
  • LV size
  • LA size
  • Age
  • Concomitant TV disease
  • CAD (3x risk)
  • Subvalvular apparatus (preservation of chordae reduces risk)
20
Q

Outcomes after MVR

A
  • Hospital mortality (non-ischemic valve disease): 2-7%
  • Hospital mortality higher for MVR+CAB
  • 10 year survival: 55%
  • 70% of MVR patients alive without compications at 5 years